{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:49:04Z","timestamp":1780638544784,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The vitreous humor of the eye presents a crucial target for posterior segment therapy due to its proximity to the retina and relatively easy accessibility. Although intravitreous injections have long been the primary method for treating posterior segment disorders, recent successes in non-invasive topical treatments have led to the exploration of alternative administration routes. The objective of our study is to establish a platform for a Parallel Artificial Membrane Permeability Assay (PAMPA) model that mimics the posterior segment, modelling the permeation process of compounds applied topically on the eye. The study demonstrates the acceptor-phase effects of sodium hyaluronate and agar on passive permeability, while applying a previously published vitreous humor-mimetic material. Physicochemical similarities of the acceptor phase media and freshly excised porcine vitreous humor further support the applicability of the mimetic material, based on viscosity and zeta potential measurement. As a result, a new concept is introduced for measuring posterior segment permeability, with potential for future high throughput screening applications.<\/jats:p>","DOI":"10.1038\/s41598-025-93425-3","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:32:31Z","timestamp":1741883551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Toward a high-throughput in vitro model for estimating vitreous humor permeability of topically applied drugs"],"prefix":"10.1038","volume":"15","author":[{"given":"Anna","family":"Vincze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Kopl\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef Gergely","family":"Stankovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di\u00e1na","family":"Balogh-Weiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benj\u00e1min","family":"Gyarmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n Zsolt","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy T.","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"93425_CR1","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","volume":"57","author":"PM Hughes","year":"2005","unstructured":"Hughes, P. M., Olejnik, O., Chang-Lin, J. E. & Wilson, C. G. Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 57, 2010\u20132032. https:\/\/doi.org\/10.1016\/j.addr.2005.09.004 (2005). 14 SPEC. ISS.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"93425_CR2","doi-asserted-by":"publisher","unstructured":"L\u00f6scher, M., Seiz, C., Hurst, J. & Schnichels, S. Topical drug delivery to the posterior segment of the eye. Pharmaceutics 14 (1). https:\/\/doi.org\/10.3390\/pharmaceutics14010134 (2022).","DOI":"10.3390\/pharmaceutics14010134"},{"issue":"5","key":"93425_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/17425247.5.5.567","volume":"5","author":"J Barar","year":"2008","unstructured":"Barar, J., Javadzadeh, A. R. & Omidi, Y. Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin. Drug Deliv. 5 (5), 567\u2013581. https:\/\/doi.org\/10.1517\/17425247.5.5.567 (2008).","journal-title":"Expert Opin. Drug Deliv."},{"key":"93425_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000455276","volume":"58","author":"E Moisseiev","year":"2017","unstructured":"Moisseiev, E. & Loewenstein, A. Drug delivery to the posterior segment of the eye. Dev. Ophthalmol. 58, 87\u2013101. https:\/\/doi.org\/10.1159\/000455276 (2017).","journal-title":"Dev. Ophthalmol."},{"issue":"1","key":"93425_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000455276","volume":"5","author":"SS Shah","year":"2010","unstructured":"Shah, S. S., Denham, L. V. & Elison, J. R. Drug delivery to the posterior segment of the eye for Pharmacologic therapy. Expert Rev. Ophthalmol. 5 (1), 75\u201393. https:\/\/doi.org\/10.1159\/000455276 (2010).","journal-title":"Expert Rev. Ophthalmol."},{"issue":"1","key":"93425_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/108076804772745419","volume":"20","author":"J Inoue","year":"2004","unstructured":"Inoue, J. et al. Effects of dorzolamide hydrochloride on ocular tissues. J. Ocul. Pharmacol. Ther. 20 (1), 1\u201313. https:\/\/doi.org\/10.1089\/108076804772745419 (2004).","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"4","key":"93425_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1124\/dmd.30.4.421","volume":"30","author":"AA Acheampong","year":"2002","unstructured":"Acheampong, A. A. et al. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes. Drug Metab. Dispos. 30 (4), 421\u2013429. https:\/\/doi.org\/10.1124\/dmd.30.4.421 (2002).","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"93425_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1167\/iovs.05-0945","volume":"47","author":"G Holl\u00f3","year":"2006","unstructured":"Holl\u00f3, G. et al. Concentrations of betaxolol in ocular tissues of patients with glaucoma and normal monkeys after 1 month of topical ocular administration. Invest. Ophthalmol. Visual Sci. 47 (1), 235\u2013240. https:\/\/doi.org\/10.1167\/iovs.05-0945 (2006).","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"93425_CR9","doi-asserted-by":"publisher","unstructured":"Lin, C. W. et al. Discovery and preclinical development of Netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma. J. Ocul. Pharmacol. Ther. 34, 1\u20132. https:\/\/doi.org\/10.1089\/jop.2017.0023 (Jan. 2018).","DOI":"10.1089\/jop.2017.0023"},{"issue":"12","key":"93425_CR10","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s11095-006-9106-2","volume":"23","author":"MJ Koeberle","year":"2006","unstructured":"Koeberle, M. J., Hughes, P. M., Skellern, G. G. & Wilson, C. G. Pharmacokinetics and disposition of memantine in the arterially perfused bovine eye. Pharm. Res. 23 (12), 2781\u20132798. https:\/\/doi.org\/10.1007\/s11095-006-9106-2 (2006).","journal-title":"Pharm. Res."},{"key":"93425_CR11","doi-asserted-by":"publisher","unstructured":"Davis, B. M. et al. Apr., Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-associated Liposomes, Small, vol. 10, no. 8, pp. 1575\u20131584, (2014). https:\/\/doi.org\/10.1002\/SMLL.201303433","DOI":"10.1002\/SMLL.201303433"},{"key":"93425_CR12","doi-asserted-by":"publisher","unstructured":"Balguri, S. P., Adelli, G. R. & Majumdar, S. Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues, European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, vol. 109, pp. 224\u2013235, Dec. (2016). https:\/\/doi.org\/10.1016\/J.EJPB.2016.10.015","DOI":"10.1016\/J.EJPB.2016.10.015"},{"key":"93425_CR13","doi-asserted-by":"publisher","unstructured":"Schnichels, S. et al. Mar., Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles, ACS applied materials & interfaces, vol. 13, no. 8, pp. 9445\u20139456, (2021). https:\/\/doi.org\/10.1021\/ACSAMI.0C18626","DOI":"10.1021\/ACSAMI.0C18626"},{"key":"93425_CR14","doi-asserted-by":"publisher","unstructured":"Johannsdottir, S. et al. Jun., Topical drug delivery to the posterior segment of the eye: Dexamethasone concentrations in various eye tissues after topical administration for up to 15 days to rabbits, Journal of Drug Delivery Science and Technology, vol. 45, pp. 449\u2013454, (2018). https:\/\/doi.org\/10.1016\/J.JDDST.2018.04.007","DOI":"10.1016\/J.JDDST.2018.04.007"},{"key":"93425_CR15","doi-asserted-by":"publisher","unstructured":"Xu, X., Sun, L., Zhou, L., Cheng, Y. & Cao, F. Functional Chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone. Carbohydr. Polym. 227, 115356. https:\/\/doi.org\/10.1016\/J.CARBPOL.2019.115356 (Jan. 2020).","DOI":"10.1016\/J.CARBPOL.2019.115356"},{"issue":"1","key":"93425_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/10717544.2019.1571122","volume":"26","author":"J Li","year":"2019","unstructured":"Li, J. et al. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye. Drug Deliv. 26 (1), 188\u2013198. https:\/\/doi.org\/10.1080\/10717544.2019.1571122 (2019).","journal-title":"Drug Deliv."},{"issue":"5","key":"93425_CR17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1755-3768.1991.tb04849.x","volume":"69","author":"J Waga","year":"1991","unstructured":"Waga, J., Ohta, A. & Ehinger, B. Intraocular Microdialysis with permanently implanted probes in rabbit. Acta Ophthalmol. 69 (5), 618\u2013624. https:\/\/doi.org\/10.1111\/j.1755-3768.1991.tb04849.x (1991).","journal-title":"Acta Ophthalmol."},{"issue":"11","key":"93425_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/BF00921960","volume":"231","author":"N Stempels","year":"1993","unstructured":"Stempels, N., Tassignon, M. J. & Sarre, S. A removable ocular Microdialysis system for measuring vitreous biogenic amines. Graefe\u2019s Archive Clin. Experimental Ophthalmol. 231 (11), 651\u2013655. https:\/\/doi.org\/10.1007\/BF00921960 (1993).","journal-title":"Graefe\u2019s Archive Clin. Experimental Ophthalmol."},{"key":"93425_CR19","doi-asserted-by":"publisher","unstructured":"Prieto, E. et al. Dexamethasone delivery to the ocular posterior segment by sustained-release laponite formulation. Biomedical Mater. (Bristol). 15 (6). https:\/\/doi.org\/10.1088\/1748-605X\/aba445 (2020).","DOI":"10.1088\/1748-605X\/aba445"},{"key":"93425_CR20","doi-asserted-by":"publisher","unstructured":"Maurice, D. M. Drug delivery to the posterior segment from drops, Survey of Ophthalmology, vol. 47, no. 4 SUPPL. 1, (2002). https:\/\/doi.org\/10.1016\/S0039-6257(02)00326-0","DOI":"10.1016\/S0039-6257(02)00326-0"},{"issue":"12","key":"93425_CR21","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1016\/j.xphs.2018.08.013","volume":"107","author":"H Shelley","year":"2018","unstructured":"Shelley, H., Rodriguez-Galarza, R. M., Duran, S. H., Abarca, E. M. & Babu, R. J. In situ gel formulation for enhanced ocular delivery of Nepafenac. J. Pharm. Sci. 107 (12), 3089\u20133097. https:\/\/doi.org\/10.1016\/j.xphs.2018.08.013 (2018).","journal-title":"J. Pharm. Sci."},{"key":"93425_CR22","doi-asserted-by":"publisher","unstructured":"Loch, C., Nagel, S., Guthoff, R., Seidlitz, A. & Weitschies, W. The vitreous model - A new in vitro test method simulating the vitreous body, Biomedizinische Technik, vol. 57, no. SUPPL. 1 TRACK-O, pp. 281\u2013284, (2012). https:\/\/doi.org\/10.1515\/bmt-2012-4106","DOI":"10.1515\/bmt-2012-4106"},{"key":"93425_CR23","doi-asserted-by":"publisher","unstructured":"Henein, C. et al. Hydrodynamics of intravitreal injections into liquid vitreous substitutes, Pharmaceutics, vol. 11, no. 8, pp. 1\u201319, (2019). https:\/\/doi.org\/10.3390\/pharmaceutics11080371","DOI":"10.3390\/pharmaceutics11080371"},{"key":"93425_CR24","doi-asserted-by":"crossref","unstructured":"M. P. Kummer, J. J. Abbott, S. Dinser, and B. J. Nelson, Artificial vitreous humor for in vitro experiments., Conference proceedings: \u2026 Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society.Conference, pp. 6407\u20136410, 2007.","DOI":"10.1109\/IEMBS.2007.4353822"},{"issue":"10","key":"93425_CR25","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1002\/jps.24480","volume":"104","author":"S Awwad","year":"2015","unstructured":"Awwad, S., Lockwood, A., Brocchini, S. & Khaw, P. T. The PK-Eye: A novel in vitro ocular flow model for use in preclinical drug development. J. Pharm. Sci. 104 (10), 3330\u20133342. https:\/\/doi.org\/10.1002\/jps.24480 (2015).","journal-title":"J. Pharm. Sci."},{"key":"93425_CR26","doi-asserted-by":"publisher","unstructured":"Darg\u00f3, G. et al. Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability, European Journal of Pharmaceutical Sciences, vol. 128, no. December pp. 232\u2013239, 2019, (2018). https:\/\/doi.org\/10.1016\/j.ejps.2018.12.012","DOI":"10.1016\/j.ejps.2018.12.012"},{"issue":"6","key":"93425_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1021\/jm001020e","volume":"44","author":"F Wohnsland","year":"2001","unstructured":"Wohnsland, F. & Faller, B. High-throughput permeability pH profile and high-throughput alkane\/water log P with artificial membranes. J. Med. Chem. 44 (6), 923\u2013930. https:\/\/doi.org\/10.1021\/jm001020e (2001).","journal-title":"J. Med. Chem."},{"key":"#cr-split#-93425_CR28.1","unstructured":"ACD\/Labs Percepta, version: 2019.1.0"},{"key":"#cr-split#-93425_CR28.2","unstructured":"Accessed: Sep 04, 2024, (2020). https:\/\/www.acdlabs.com\/products\/percepta\/. Advanced Chemistry Development, Inc., Toronto, Canada: 2019.1.0."},{"key":"93425_CR29","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, 46, pp. 3\u201326, (2001)."},{"key":"93425_CR30","doi-asserted-by":"crossref","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates, pp. 2615\u20132623, (2002).","DOI":"10.1021\/jm020017n"},{"key":"93425_CR31","doi-asserted-by":"publisher","unstructured":"Vincze, A., Darg\u00f3, G., R\u00e1cz, A. & Balogh, G. T. A corneal-PAMPA-based in Silico model for predicting corneal permeability. J. Pharm. Biomed. Anal. 203 https:\/\/doi.org\/10.1016\/j.jpba.2021.114218 (2021).","DOI":"10.1016\/j.jpba.2021.114218"},{"issue":"1","key":"93425_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/bm040050m","volume":"6","author":"I Gatej","year":"2005","unstructured":"Gatej, I., Popa, M. & Rinaudo, M. Role of the pH on hyaluronan behavior in aqueous solution. Biomacromolecules 6 (1), 61\u201367. https:\/\/doi.org\/10.1021\/bm040050m (2005).","journal-title":"Biomacromolecules"},{"key":"93425_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejpb.2020.01.008","volume":"148","author":"SS Thakur","year":"2020","unstructured":"Thakur, S. S., Shenoy, S. K., Suk, J. S., Hanes, J. S. & Rupenthal, I. D. Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations. Eur. J. Pharm. Biopharm. 148, 118\u2013125. https:\/\/doi.org\/10.1016\/j.ejpb.2020.01.008 (2020).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"93425_CR34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1023\/A:1007517912927","volume":"17","author":"J Xu","year":"2000","unstructured":"Xu, J., Heys, J. J., Barocas, V. H. & Randolph, T. W. Permeability and diffusion in vitreous humor: implications for drug delivery. Pharm. Res. 17 (6), 664\u2013669. https:\/\/doi.org\/10.1023\/A:1007517912927 (2000).","journal-title":"Pharm. Res."},{"issue":"4","key":"93425_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3233\/BIR-1994-31404","volume":"31","author":"B Lee","year":"1994","unstructured":"Lee, B., Litt, M. & Buchsbaum, G. Rheology of the vitreous body: part 3. Concentration of electrolytes, collagen and hyaluronic acid. Biorheology 31 (4), 339\u2013351. https:\/\/doi.org\/10.3233\/BIR-1994-31404 (1994).","journal-title":"Biorheology"},{"key":"93425_CR36","unstructured":"AgarGel & Corporation Properties of agar-agar \/http:\/\/www.agargel.com.br\/agar.html\/. Accessed on Feb 2, 2024."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93425-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:32:39Z","timestamp":1741883559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93425-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93425"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93425-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8768"}}